The panel, consisting of Geraldine O’keeffe (Partner at LSP), Arthur Franken (Partner at Gilde), Krijn de Nood (CEO of Meatable) and Jan de Kerpel (Managing director of Kempen), will reflect on how to raise capital during and after the pandemic, and how today’s crisis will affect both biotech businesses, capital markets and investors.
Registration is required (free of charge).
Image: Serhiy Chaiko/Shutterstock
